BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Deluxe
DLX
$1.15B
| $255M | 0.01% |
5,103,495
+45,465
| +0.9% | +$2.26M |
|
|
AVP
1302
DELISTED
Avon Products, Inc.
AVP
| $255M | 0.01% |
45,150,427
+2,067,719
| +5% | +$9.61M |
|
1303
MGIC Investment
MTG
$6.25B
| $255M | 0.01% |
17,966,749
+927,132
| +5% | +$12.9M |
|
1304
Envista
NVST
$4.52B
| $254M | 0.01% |
8,579,377
+5,949,500
| +226% | +$169M |
|
1305
Sally Beauty Holdings
SBH
$1.58B
| $254M | 0.01% |
13,916,888
-312,835
| -2% | -$5.44M |
|
1306
State Street Industrial Select Sector SPDR ETF
XLI
$33.7B
| $253M | 0.01% |
3,110,975
+1,369,633
| +79% | +$109M |
|
|
PDCO
1307
DELISTED
Patterson Companies, Inc.
PDCO
| $253M | 0.01% |
12,365,234
+1,794,143
| +17% | +$34M |
|
1308
Belden
BDC
$5.19B
| $252M | 0.01% |
4,588,550
+83,769
| +2% | +$4.47M |
|
1309
Matador Resources
MTDR
$6.09B
| $252M | 0.01% |
13,995,518
+629,261
| +5% | +$9.41M |
|
|
AMWD
1310
DELISTED
American Woodmark
AMWD
| $251M | 0.01% |
2,404,668
-14,913
| -0.6% | -$1.5M |
|
1311
Commault Systems
CVLT
$5.61B
| $251M | 0.01% |
5,621,647
+796,705
| +17% | +$37.7M |
|
1312
EQT Corp
EQT
$32.3B
| $251M | 0.01% |
23,019,574
+393,542
| +2% | +$3.85M |
|
1313
PRA Group
PRAA
$755M
| $251M | 0.01% |
6,909,107
+86,427
| +1% | +$3.06M |
|
|
NUAN
1314
DELISTED
Nuance Communications, Inc.
NUAN
| $250M | 0.01% |
14,039,157
-1,916,023
| -12% | -$31.8M |
|
|
CMD
1315
DELISTED
Cantel Medical Corporation
CMD
| $249M | 0.01% |
3,515,502
+92,264
| +3% | +$6.69M |
|
1316
iShares MSCI USA Size Factor ETF
SIZE
$442M
| $249M | 0.01% |
2,557,355
+2,037,379
| +392% | +$190M |
|
1317
Walker & Dunlop
WD
$1.53B
| $249M | 0.01% |
3,849,726
-400,933
| -9% | -$25.4M |
|
1318
Ligand Pharmaceuticals
LGND
$6.36B
| $249M | 0.01% |
3,823,408
-118,218
| -3% | -$7.9M |
|
1319
Graphic Packaging
GPK
$3.58B
| $249M | 0.01% |
14,931,842
-758,467
| -5% | -$12M |
|
|
INN
1320
Summit Hotel Properties
INN
$700M
| $248M | 0.01% |
20,059,012
+368,176
| +2% | +$4.42M |
|
1321
Cabot Corp
CBT
$4.52B
| $247M | 0.01% |
5,203,174
-48,559
| -0.9% | -$2.25M |
|
|
CIM
1322
Chimera Investment
CIM
$1B
| $247M | 0.01% |
4,006,784
-22,998
| -0.6% | -$1.4M |
|
1323
US Physical Therapy
USPH
$1.22B
| $247M | 0.01% |
2,159,684
-11,615
| -0.5% | -$1.45M |
|
1324
Gibraltar Industries
ROCK
$1.49B
| $247M | 0.01% |
4,891,891
+98,016
| +2% | +$4.92M |
|
1325
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.59B
| $247M | 0.01% |
6,380,495
+1,130,529
| +22% | +$43.7M |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.